Clinical data sharing agreements
Data-sharing paper between sponsor, CRO, hospital and University that stands up to a joint-controller analysis.
Life sciences businesses around Oxford handle some of the UK's most sensitive personal data — clinical trial records, genomic data, NHS research collaborations — under regimes where GDPR sits alongside sector-specific rules the standard templates never contemplate.
Diagnostics, therapeutics, digital-health and health-tech companies operating out of Oxford, Harwell, Milton Park and the wider bioscience cluster.
Oxford's life-sciences ecosystem sits inside a tight network of University research, NHS trusts, contract research organisations and international pharma partners — each with distinct data-sharing paper.
Commercial matters involving Oxford businesses are typically dealt with at the Oxford Combined Court for County Court proceedings and Reading Employment Tribunal for employment claims. The commercial counterparty mix is shaped by the University, the NHS trusts around the John Radcliffe and the deep concentration of research-led occupiers at Begbroke, Harwell and the Oxford Science Park.
Data-sharing paper between sponsor, CRO, hospital and University that stands up to a joint-controller analysis.
Assessments and evidence packs to satisfy NHS partner requirements before contracts are signed.
IDTA, SCCs and TIA packs so US and EU collaborations don't stall at the DPO stage.
Joint-controller relationships not documented, exposing both parties on regulator inspection.
Explicit joint-controller arrangements under Art. 26 with clear roles.
Genetic and health data treated as ordinary special-category data.
Article 9 lawful basis mapped explicitly with UK Data Protection Act 2018 Schedule 1 conditions.
Speak to Radcliffe Enterprise Law for clear, commercial legal advice — by phone, video or in person.
Start the conversation